Top Markets
Coin of the day
Pell Bio-Med Technology Co., Ltd. Pell Bio-Med Technology Co., Ltd.

Pell Bio-Med Technology Co., Ltd.

6949
Rankning i aktier #4993
Pell Bio-Med Technology Co., Ltd., established in 2017 and headquartered in... Pell Bio-Med Technology Co., Ltd., established in 2017 and headquartered in Taipei, Taiwan, operates as a biomedical firm specializing in advanced cell culture technologies and methods for therapeutic applications. The company's commercial portfolio encompasses good tissue practice (GTP) laboratory infrastructure, adipose-derived stem cells (ADSC) utilized in regenerative medicine, and both CIK and DC-CIK therapies aimed at combating various cancers. Beyond its existing products, Pell Bio-Med is actively engaged in developing novel pharmaceuticals for diverse cancer types, pioneering cell immunotherapy strategies, and advancing stem cell regenerative therapy techniques. Its research and development efforts extend to cutting-edge areas such as chimeric antigen receptor T cell (CAR-T), CAR-NK, CAR-?dT, and genetically modified ADSC technologies. The company is also progressing product development specifically targeting indications like B-cell non-Hodgkin lymphoma (B-NHL), ovarian cancer, multiple myeloma, and thyroid cancer.
Aktiekurs
$47.38
Senast synkroniserad: 2026-08-26
Marknadsvärde
$3.11B
Förändring (1 dag)
9.96%
Förändring (1 år)
238.59%
Land
TW
Handel Pell Bio-Med Technology Co., Ltd. (6949)

Kategori

Aktiekurshistorik för Pell Bio-Med Technology Co., Ltd. (6949)
Högsta slutkurs: $35.36 den 2026-08-01

Lägsta slutkurs: $2.71 den 2024-03-01
Aktiekurshistorik för Pell Bio-Med Technology Co., Ltd. från 2024 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 64.40%
2025 354.23%
2024 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$549.38 41.20%
US
$1.05K 47.75%
NL
$148.35 491.02%
US
$122.47 -12.76%
AU
$764.47 7.08%
CH